(Q36996612)

17 August 2017

1 reference

title

Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies (English)

1 reference

17 August 2017

1 reference

2

Ernst J Kuipers

1 reference

17 August 2017

Annemarie C de Vries

1

1 reference

17 August 2017

publication date

1 November 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

12 Suppl 2

1 reference

17 August 2017

page(s)

22-31

1 reference

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Evaluation of a mass screening program for stomach cancer with a case-control study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Review article: pre-neoplastic states of the gastric mucosa--a practical approach for the perplexed clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

The long term outcome of gastric non-invasive neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

The long term results of endoscopic surveillance of premalignant gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Long-term sequelae of Helicobacter pylori gastritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

H. pylori and gastric cancer: the Asian enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Prevalence of chronic atrophic gastritis in different parts of the world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: relations to symptomatology and life-style.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Seroconversion for Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Meta-analysis of the relationship between cagA seropositivity and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

The risk of stomach cancer in patients with gastric or duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Helicobacter pylori and atrophic gastritis: importance of the cagA status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Helicobacter pylori virulence factors—one part of a big picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Tobacco smoking and gastric cancer: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Cigarette Smoking and Other risk Factors for progression of Precancerous Stomach Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Serum micronutrients in relation to pre-cancerous gastric lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

The Vienna classification of gastrointestinal epithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Gastrointestinal epithelial neoplasia: Vienna revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Gastric dysplasia: the Padova international classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Relationship between histopathologic gastritis and mucosal microvascularity: observations with magnifying endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Comparison between magnifying endoscopy and histological, culture and urease test findings from the gastric mucosa of the corpus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Intestinal metaplasia of the gastric cardia: A prospective study with enhanced magnification endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Routine endoscopy using a magnifying endoscope for gastric cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Evaluation of in vivo endoscopic autofluorescence spectroscopy in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Endoscopic mucosal resection for treatment of early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Gastric intestinal metaplasia: subtypes and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Host–bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00562.X

10.1111/J.1523-5378.2007.00562.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference